Literature DB >> 28243503

Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure.

Mehmet A Topcuoglu1, Ruchira M Jha1, Jacob George1, Matthew P Frosch1, Aneesh B Singhal1.   

Abstract

BACKGROUND: Primary angiitis of the CNS (PACNS) typically manifests with accumulating neurologic deficits from ischemic strokes. Intracerebral hemorrhage (ICH) is an uncommon complication. There is limited knowledge about the risk factors and features of hemorrhagic PACNS.
METHODS: We identified 49 patients (20 biopsy-proven) with PACNS diagnosed at our hospital from 1993 to 2015. We compared the features of hemorrhagic and nonhemorrhagic PACNS and analyzed the hemorrhagic PACNS cases in detail.
RESULTS: The mean age was 51 ± 15 years; 13 patients were men. Five patients had ICH (mean age 52 ± 14 years; 4 men) including 4 where ICH was the first manifestation of PACNS. All ICH patients reported recent exposure to sympathomimetic drugs (e.g., diet pills, nasal decongestants). Patients with ICH had higher rates of headache (100% vs 43%, p = 0.022), especially thunderclap headache (60% vs 0%, p = 0.001), and eosinophilic vascular infiltrates on brain biopsy (50% vs 9%, p = 0.084). In all ICH patients, brain MRI showed lobar hemorrhages with concurrent punctate diffusion-restricted lesions, suggesting an acute inflammatory process. Four received a short course of immunosuppressive therapy. All patients showed complete clinical resolution or significant improvement within weeks.
CONCLUSIONS: In this study, hemorrhagic PACNS was exclusively associated with sympathomimetic drug exposure. The high rate of thunderclap headache, lobar hemorrhages, and the self-limited clinical course suggests a shared mechanism between hemorrhagic PACNS and the reversible cerebral vasoconstriction syndrome (RCVS), a PACNS mimic. This RCVS-PACNS overlap syndrome may result from sympathomimetic drug-induced prolonged distal vasoconstriction, culminating in inflammation.

Entities:  

Year:  2017        PMID: 28243503      PMCID: PMC5310206          DOI: 10.1212/CPJ.0000000000000324

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  27 in total

1.  Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome: Features and Mechanisms.

Authors:  Mehmet A Topcuoglu; Aneesh B Singhal
Journal:  Stroke       Date:  2016-06-07       Impact factor: 7.914

2.  Necrotizing angiitis associated with drug abuse.

Authors:  B P Citron; M Halpern; M McCarron; G D Lundberg; R McCormick; I J Pincus; D Tatter; B J Haverback
Journal:  N Engl J Med       Date:  1970-11-05       Impact factor: 91.245

3.  Primary central nervous system vasculitis presenting with intracranial hemorrhage.

Authors:  Carlo Salvarani; Robert D Brown; Kenneth T Calamia; Teresa J H Christianson; John Huston; James F Meschia; Caterina Giannini; Dylan V Miller; Gene G Hunder
Journal:  Arthritis Rheum       Date:  2011-11

4.  Cerebral angiographic changes in the drug abuse patient.

Authors:  C L Rumbaugh; R T Bergeron; H C Fang; R McCormick
Journal:  Radiology       Date:  1971-11       Impact factor: 11.105

Review 5.  Primary angiitis of the CNS.

Authors:  Rula A Hajj-Ali; Aneesh B Singhal; Susanne Benseler; Eamonn Molloy; Leonard H Calabrese
Journal:  Lancet Neurol       Date:  2011-06       Impact factor: 44.182

Review 6.  Reversible cerebral vasoconstriction syndrome.

Authors:  Anne Ducros
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

7.  Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system.

Authors:  Hubert de Boysson; Mathieu Zuber; Olivier Naggara; Jean-Philippe Neau; Françoise Gray; Marie-Germaine Bousser; Isabelle Crassard; Emmanuel Touzé; Pierre-Olivier Couraud; Philippe Kerschen; Catherine Oppenheim; Olivier Detante; Anthony Faivre; Nicolas Gaillard; Caroline Arquizan; Boris Bienvenu; Antoine Néel; Loïc Guillevin; Christian Pagnoux
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

8.  Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review.

Authors:  R Glick; J Hoying; L Cerullo; S Perlman
Journal:  Neurosurgery       Date:  1987-06       Impact factor: 4.654

9.  Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs.

Authors:  Carlos Cantu; Antonio Arauz; Luis M Murillo-Bonilla; Mario López; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2003-06-05       Impact factor: 7.914

10.  Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

Authors:  C A Haller; N L Benowitz
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 176.079

View more
  4 in total

Review 1.  A Spotlight on Drug-Induced Vasculitis.

Authors:  Kinanah Yaseen; Alana Nevares; Hiromichi Tamaki
Journal:  Curr Rheumatol Rep       Date:  2022-09-21       Impact factor: 4.686

2.  Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome: analysis of the National Inpatient Sample.

Authors:  Hugo Lopez-Arevalo; Maria Emilia Romero Noboa; Dijo Joseph; Ehizogie Edigin; Shilpa Arora; Augustine Manadan
Journal:  Clin Rheumatol       Date:  2022-04-12       Impact factor: 3.650

Review 3.  Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms.

Authors:  Leonardo Biscetti; Gioacchino De Vanna; Elena Cresta; Ilenia Corbelli; Lorenzo Gaetani; Letizia Cupini; Paolo Calabresi; Paola Sarchielli
Journal:  J Neuroinflammation       Date:  2021-11-08       Impact factor: 8.322

Review 4.  Pathophysiology of reversible cerebral vasoconstriction syndrome.

Authors:  Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Biomed Sci       Date:  2022-09-21       Impact factor: 12.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.